ArticlePharmaceuticals (Basel, Switzerland)2023

Retrospective Analysis of a Real-Life Use of Tixagevimab-Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19.

Nicolina Capoluongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.